These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26243263)

  • 1. The bactericidal activity of β-lactam antibiotics is increased by metabolizable sugar species.
    Thorsing M; Bentin T; Givskov M; Tolker-Nielsen T; Goltermann L
    Microbiology (Reading); 2015 Oct; 161(10):1999-2007. PubMed ID: 26243263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial compounds of Canadian honeys target bacterial cell wall inducing phenotype changes, growth inhibition and cell lysis that resemble action of β-lactam antibiotics.
    Brudzynski K; Sjaarda C
    PLoS One; 2014; 9(9):e106967. PubMed ID: 25191847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis enhancement: a novel form of interaction between beta-lactam antibiotics.
    Greenwood D; O'Grady F
    J Med Microbiol; 1975 Feb; 8(1):205-8. PubMed ID: 1092867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
    Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H
    J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust, linear correlations between growth rates and β-lactam-mediated lysis rates.
    Lee AJ; Wang S; Meredith HR; Zhuang B; Dai Z; You L
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4069-4074. PubMed ID: 29610312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli mutants tolerant to beta-lactam antibiotics.
    Kitano K; Tomasz A
    J Bacteriol; 1979 Dec; 140(3):955-63. PubMed ID: 391807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated image analysis for quantification of filamentous bacteria.
    Fredborg M; Rosenvinge FS; Spillum E; Kroghsbo S; Wang M; Sondergaard TE
    BMC Microbiol; 2015 Nov; 15():255. PubMed ID: 26531808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.
    Skorup P; Maudsdotter L; Lipcsey M; Castegren M; Larsson A; Jonsson AB; Sjölin J
    PLoS One; 2014; 9(2):e90441. PubMed ID: 24587365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentialization of β-lactams with colistin: in case of extended spectrum β-lactamase producing Escherichia coli strains isolated from children with urinary infections.
    Al Atya AK; Drider-Hadiouche K; Vachee A; Drider D
    Res Microbiol; 2016 Apr; 167(3):215-21. PubMed ID: 26723273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial fuel cell-based diagnostic platform to reveal antibacterial effect of beta-lactam antibiotics.
    Schneider G; Czeller M; Rostás V; Kovács T
    Enzyme Microb Technol; 2015 Jun; 73-74():59-64. PubMed ID: 26002505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum β-lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model.
    Zhanel GG; Denisuik A; Vashisht S; Yachison C; Adam HJ; Hoban DJ
    J Antimicrob Chemother; 2014 Sep; 69(9):2448-52. PubMed ID: 24827891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer membrane vesicles from β-lactam-resistant Escherichia coli enable the survival of β-lactam-susceptible E. coli in the presence of β-lactam antibiotics.
    Kim SW; Park SB; Im SP; Lee JS; Jung JW; Gong TW; Lazarte JMS; Kim J; Seo JS; Kim JH; Song JW; Jung HS; Kim GJ; Lee YJ; Lim SK; Jung TS
    Sci Rep; 2018 Mar; 8(1):5402. PubMed ID: 29599474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocardicin A, a new monocyclic beta-lactam antibiotic III. In vitro evaluation.
    Nishida M; Mine Y; Nonoyama S; Kojo H
    J Antibiot (Tokyo); 1977 Nov; 30(11):917-25. PubMed ID: 412823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.
    Greenwood D; O'Grady F
    J Infect Dis; 1973 Aug; 128(2):211-22. PubMed ID: 4579140
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening of antibiotic susceptibility to β-lactam-induced elongation of Gram-negative bacteria based on dielectrophoresis.
    Chung CC; Cheng IF; Chen HM; Kan HC; Yang WH; Chang HC
    Anal Chem; 2012 Apr; 84(7):3347-54. PubMed ID: 22404714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in neutrophil death among beta-lactam antibiotics after in vitro killing of bacteria.
    Matsuda T; Saito H; Fukatsu K; Han I; Inoue T; Furukawa S; Ikeda S; Hidemura A; Kang W
    Shock; 2002 Jul; 18(1):69-74. PubMed ID: 12095137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of resistance to beta-lactam antibiotics in Escherichia coli isolated from blood from 1969-1991.
    Shannon K; King A; Phillips I
    J Antimicrob Chemother; 1992 Nov; 30(5):661-72. PubMed ID: 1493983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by D-amino acids against growth inhibition and lysis caused by beta-lactam antibiotics.
    Tuomanen E; Tomasz A
    Antimicrob Agents Chemother; 1984 Sep; 26(3):414-6. PubMed ID: 6508269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.